InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (49 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
49
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Catinazzo Thomas, Chief Financial Officer. Insider active across 2 companies, notably Relay Therapeutics, Inc.. In total, 62 filings have been published. Split: 0 buy · 49 sells. Total volume traded: €1.9m. Activity tracked since 30 March 2021. The latest transaction was disclosed on 14 August 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Catinazzo Thomas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations62 total
17,717 shares@ US$19.74Common StockSEC:0001193125-26-355493:0
1,459 shares@ US$18.610.0007% mcap1.6% of flowCommon StockSEC:0001193125-26-326144:0
17,717 shares@ US$18.690.0081% mcap20.6% of flowCommon StockSEC:0001193125-26-298679:0
17,717 sharesCommon StockSEC:0001193125-26-281061:0
56,323 sharesCommon StockSEC:0001193125-26-281061:1
56,323 sharesCommon StockSEC:0001193125-26-281061:2
61,563 sharesCommon StockSEC:0001193125-26-281061:3
61,563 sharesCommon StockSEC:0001193125-26-281061:4
51,560 sharesCommon StockSEC:0001193125-26-281061:5
51,560 sharesCommon StockSEC:0001193125-26-281061:6
17,717 shares@ US$12.860.0084% mcap24.1% of flowCommon StockSEC:0001193125-26-224545:0
972 shares@ US$14.790.0003% mcap1.4% of flowCommon StockSEC:0001193125-26-197419:0
17,717 shares@ US$13.0117.7% of flowCommon StockSEC:0001193125-26-150044:0
1,800 shares@ US$5.220.7% of flowCommon StockSEC:0001193125-26-150044:1
1,800 shares@ US$15.002.1% of flowCommon StockSEC:0001193125-26-150044:2
17,717 shares@ US$10.0610.7% of flowCommon StockSEC:0001193125-26-102270:0
13,820 shares@ US$7.626.1% of flowCommon StockSEC:0001193125-26-029403:0
21,664 shares@ US$7.2911.3% of flowCommon StockSEC:0001193125-25-258574:0
1,701 shares@ US$3.740.5% of flowCommon StockSEC:0000950170-25-100366:0
1,709 shares@ US$3.170.5% of flowCommon StockSEC:0000950170-25-061366:0
3,558 shares@ US$3.231.2% of flowCommon StockSEC:0000950170-25-061366:2
12,943 shares@ US$3.003.9% of flowCommon StockSEC:0000950170-25-061366:3
981 shares@ US$3.170.3% of flowCommon StockSEC:0000950170-25-061366:1
298 shares@ US$2.840.1% of flowCommon StockSEC:0000950170-25-047725:0
33,753 shares@ US$4.6317.1% of flowCommon StockSEC:0000950170-25-011327:0
25 of 62 declarations
About Catinazzo Thomas
Catinazzo Thomas is Directeur Financier at Relay Therapeutics, Inc. He has 60 filings in total, and in the sampled recent filings they cover the period from 2021-06-09 to 2026-07-08, with sales of EUR 1583224 and no buys.
